β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort
Higher estimated intake of beta-glucan and inulin was associated with a lower risk of Crohn’s disease in at-risk individuals and may support gut health through preserving gut barrier function, lowering inflammation, and providing favorable gut microbiome changes.
